311 related articles for article (PubMed ID: 2897925)
1. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
Butkerait P; Friedman E
Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
[TBL] [Abstract][Full Text] [Related]
2. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
Ushijima I; Noda Y; Mizuki Y; Yamada M
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
[TBL] [Abstract][Full Text] [Related]
3. Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.
Vaccheri A; Dall'Olio R; Gandolfi O; Roncada P; Montanaro N
Psychopharmacology (Berl); 1987; 91(3):394-6. PubMed ID: 2882541
[TBL] [Abstract][Full Text] [Related]
4. D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy.
Chipkin RE; McQuade RD; Iorio LC
Pharmacol Biochem Behav; 1987 Dec; 28(4):477-82. PubMed ID: 2893388
[TBL] [Abstract][Full Text] [Related]
5. The effects of scopolamine pretreatment on stereotyped behavior induced by apomorphine in rats withdrawn from long-term haloperidol administration.
De-Souza H; Palermo-Neto J
Braz J Med Biol Res; 1981 Oct; 14(4-5):281-4. PubMed ID: 7201335
[TBL] [Abstract][Full Text] [Related]
6. Similarity of clozapine and SCH 23390 in reserpinized rats suggests a common mechanism of action.
Chipkin RE; Latranyi MB
Eur J Pharmacol; 1987 Apr; 136(3):371-5. PubMed ID: 2886345
[TBL] [Abstract][Full Text] [Related]
7. Catalepsy induced by SCH 23390 in rats.
Morelli M; Di Chiara G
Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
[TBL] [Abstract][Full Text] [Related]
8. Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat.
Parashos SA; Barone P; Marin CA; Paraschos AJ; Kapitzoglou-Logothetis V; Chase TN
Psychopharmacology (Berl); 1989; 98(2):189-92. PubMed ID: 2569216
[TBL] [Abstract][Full Text] [Related]
9. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
[TBL] [Abstract][Full Text] [Related]
10. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
11. Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
Glenthøj B
Psychopharmacology (Berl); 1993; 113(2):157-66. PubMed ID: 7855176
[TBL] [Abstract][Full Text] [Related]
12. Clonidine sensitizes mice for apomorphine-induced stereotypic gnawing: antagonism by neuroleptics and cholecystokinin-like peptides.
Zetler G
Eur J Pharmacol; 1985 May; 111(3):309-18. PubMed ID: 2862047
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic activity of ascorbic acid (vitamin C) on dopaminergic modulation: apomorphine-induced stereotypic behavior in mice.
Deshpande C; Dhir A; Kulkarni SK
Pharmacology; 2006; 77(1):38-45. PubMed ID: 16569938
[TBL] [Abstract][Full Text] [Related]
14. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
15. Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.
Dall'Olio R; Gandolfi O; Roncada P; Vaccheri A; Montanaro N
Psychopharmacology (Berl); 1990; 100(4):560-2. PubMed ID: 1969667
[TBL] [Abstract][Full Text] [Related]
16. Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats.
Chipkin RE
Pharmacol Biochem Behav; 1988 Jul; 30(3):683-6. PubMed ID: 2974995
[TBL] [Abstract][Full Text] [Related]
17. Reduction of dopaminergic supersensitivity by a single dose of amphetamine.
Haracz JL; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):131-3. PubMed ID: 6106902
[TBL] [Abstract][Full Text] [Related]
18. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
Smith RC; Davis JM
Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.
Christensen AV; Arnt J; Hyttel J; Larsen JJ; Svendsen O
Life Sci; 1984 Apr; 34(16):1529-40. PubMed ID: 6144029
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute and chronic carbamazepine administration on apomorphine-elicited stereotypy.
Barros HM; Leite JR
Eur J Pharmacol; 1986 Apr; 123(3):345-9. PubMed ID: 3720822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
